Bill Crossman is President, CEO and Board Member of Phoenix PharmaLabs, Inc. He joined the company in 2010. Mr. Crossman is a senior management professional with international and domestic experience as CEO, COO and CFO of enterprises ranging from entrepreneurial start-ups to Fortune 500 level companies. He has a proven track record of successfully commercializing emerging technologies in various fields including manufacturing and industrial systems, computer software, marine bioremediation, nanotechnology and life sciences. Mr.Crossman has assisted numerous early-stage companies to refine business strategies, commercialize new products, raise capital, license technologies, scale revenues and production, and expand into global markets. Bill holds a BS degree from the U.S. Merchant Marine Academy at Kings Point and a MBA from the Haas School of Business at the University of California – Berkeley.
Speaking In
[Available On-Demand]
Phoenix PharmaLabs (PPL) is a preclinical drug discovery company developing, potent, safe, non…